Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy
ChemMedChem · 2026
DOI: 10.1002/cmdc.202500794 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Lixiao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21000…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Antineoplastic Agents, Chaperonins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province of China.
Abstract (Originalsprache)
Cell division cycle 37 (CDC37) is a kinase‐specific HSP90 cochaperone that stabilizes oncogenic kinases and is frequently overexpressed in malignancies, making it a compelling therapeutic target. Herein, we systematically delineate therapeutic strategies aimed at inhibiting CDC37, including modulating its Ser13 phosphorylation switch through CK2 inhibition or PP5 activation, disrupting the CDC37‐HSP90 complex, and blocking its interaction with kinase clients. These approaches culminate in the concerted degradation of multiple kinase client proteins. CDC37 inhibitors induce cell cycle arrest and apoptosis in models of colon cancer, prostate cancer, and others. Critically, by disrupting the thermal stability of kinases, CDC37‐targeting agents can resensitize resistant tumors to kinase inhibitors. In summary, targeting CDC37 is not only a novel anticancer strategy but also a paradigm‐shifting approach to address the persistent challenge of kinase inhibitor resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China.
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
ORCID-Profile: Qidong You, Lei Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province of China
Zitieren
APA
Zhang, L., Xin, Y., You, Q., & Wang, L. (2026). Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy. ChemMedChem. https://doi.org/10.1002/cmdc.202500794
Vancouver
Zhang L, Xin Y, You Q, Wang L. Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy. ChemMedChem. 2026. doi:10.1002/cmdc.202500794
BibTeX
@article{Zhang2026,
author = {Zhang, Lixiao and Xin, Yuting and You, Qidong and Wang, Lei},
title = {Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202500794}
}
EUVIMED